Gringeri A - Search Results

1

Use of recombinant factor VIII in the management of hemophilia.

Mannucci PM, Gringeri A, Cattaneo M. Mannucci PM, et al. Among authors: gringeri a. Curr Stud Hematol Blood Transfus. 1991;(58):46-51. doi: 10.1159/000419336. Curr Stud Hematol Blood Transfus. 1991. PMID: 1954773 Review. No abstract available.

2

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group.

Gringeri A, Mantovani LG, Scalone L, Mannucci PM; COCIS Study Group. Gringeri A, et al. Blood. 2003 Oct 1;102(7):2358-63. doi: 10.1182/blood-2003-03-0941. Epub 2003 Jun 19. Blood. 2003. PMID: 12816859 Free article.

3

Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.

Mannucci PM, Gringeri A, de Biasi R, Baudo F, Morfini M, Ciavarella N. Mannucci PM, et al. Among authors: gringeri a. Thromb Haemost. 1992 Mar 2;67(3):310-3. Thromb Haemost. 1992. PMID: 1353642 Clinical Trial.

4

Adverse effects of treatment with porcine factor VIII.

Gringeri A, Santagostino E, Tradati F, Giangrande PL, Mannucci PM. Gringeri A, et al. Thromb Haemost. 1991 Mar 4;65(3):245-7. Thromb Haemost. 1991. PMID: 1904652

5

Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.

Gringeri A, Santagostino E, Mannucci PM. Gringeri A, et al. Haemostasis. 1991;21(1):1-4. doi: 10.1159/000216194. Haemostasis. 1991. PMID: 1907588

6

The use of recombinant factor VIII in the management of hemophilia.

Mannucci PM, Gringeri A. Mannucci PM, et al. Among authors: gringeri a. Ric Clin Lab. 1991 Jan-Mar;21(1):1-7. doi: 10.1007/BF02919111. Ric Clin Lab. 1991. PMID: 1907760

7

Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.

Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD. Mannucci PM, et al. Among authors: gringeri a. Blood. 1990 Dec 15;76(12):2540-5. Blood. 1990. PMID: 2265248 Free article. Clinical Trial.

8

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.

Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU, Purcell RH. Mannucci PM, et al. Among authors: gringeri a. Ann Intern Med. 1994 Jan 1;120(1):1-7. doi: 10.7326/0003-4819-120-1-199401010-00001. Ann Intern Med. 1994. PMID: 7504424

9

Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.

Cattaneo M, Simoni L, Gringeri A, Mannucci PM. Cattaneo M, et al. Among authors: gringeri a. Br J Haematol. 1994 Feb;86(2):333-7. doi: 10.1111/j.1365-2141.1994.tb04735.x. Br J Haematol. 1994. PMID: 8199023

10

Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.

Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Thromb Haemost. 1995 Aug;74(2):619-21. Thromb Haemost. 1995. PMID: 8584995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters